Evidence map›Paper›PMID 40634706›Full record

ArticleNature genetics2025

Enhancer adoption by an LTR retrotransposon generates viral-like particles, causing developmental limb phenotypes.

Juliane Glaser, Giulia Cova, Beatrix Fauler, Cesar A Prada-Medina, Virginie Stanislas, Mai H Q Phan, Robert Schöpflin, Yasmin Aktas, Martin Franke, Guillaume Andrey and 7 more

Abstract read
In one paragraph

Article in Nature genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Juliane GlaserRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany. glaserj@ie-freiburg.mpg.de.ORCID http://orcid.org/0000-0001-6745-6924
Giulia CovaRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0001-6489-8807
Beatrix FaulerMicroscopy and Cryo-electron Microscopy Service Group, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Cesar A Prada-MedinaRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Virginie StanislasDepartment of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0002-2786-4349
Mai H Q PhanRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Robert SchöpflinRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Yasmin AktasRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Martin FrankeRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0002-4626-3290
Guillaume AndreyRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0002-0911-4907
Natalia BartzokaRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Christina PaliouRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Verena LaupertDepartment of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Wing-Lee ChanInstitute for Medical and Human Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Lars WittlerDepartment of Developmental Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Thorsten MielkeMicroscopy and Cryo-electron Microscopy Service Group, Max Planck Institute for Molecular Genetics, Berlin, Germany.ORCID http://orcid.org/0000-0001-9275-3146
Stefan MundlosRG Development & Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany. mundlos@molgen.mpg.de.ORCID http://orcid.org/0000-0002-9788-3166

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) MU 880/16-1Human Frontier Science Program (HFSP) LT000465/2019-LNational Centre of Competence in Research Robotics (Swiss National Center of Competence in Research "Robotics") PP00P3_210995-6Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) PP00P3_176802
6 · The paper itself

Abstract

Transposable elements (TEs) are scattered across mammalian genomes. Silencing of TEs prevents harmful effects caused by either global activation leading to genome instability or insertional mutations disturbing gene transcription. However, whether the activation of a TE can cause disease without directly affecting gene expression is largely unknown. Here we show that a TE insertion can adopt nearby regulatory activity, resulting in the production of cell-type-specific viral-like particles (VLPs) that affect embryo formation. Failure to silence an LTR retrotransposon inserted upstream of the Fgf8 gene results in their co-expression during mouse development. VLP assembly in the Fgf8-expressing cells of the developing limb triggers apoptotic cell death, resulting in a limb malformation resembling human ectrodactyly. The phenotype can be rescued by mutating the retrotransposon coding sequence, thus preventing its full endogenous retroviral cycle. Our findings illustrate that TE insertions can be incorporated into the local genomic regulatory landscape and that VLP production in post-implantation embryos can cause developmental defects.

Indexed as

Enhancer Elements, GeneticExtremitiesLimb Deformities, CongenitalRetroelementsTerminal Repeat SequencesVirionAnimalsFemaleFibroblast Growth Factor 8Gene Expression Regulation, DevelopmentalHumansMicePhenotypeFgf8 protein, mouseFibroblast Growth Factor 8Retroelements

Identifiers

PMID40634706
PMCPMC12283350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.